Metabolic syndrome in a screened worksite sample: Prevalence and predictors

Cardiology

Volumn 103, Issue 3, 2005, Pages 131-136

  Godefroi, Robert ^a   Klementowicz, Peter ^a   Pepler, Catherine ^a   Lewis, Barbara ^b   McDonough, Kenneth ^b   Goldberg, Robert J ^c  

^a BAE SYSTEMS   (United States)

^b ASTRAZENECA   (United Kingdom)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Metabolic syndrome; Screening program, worksite

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEART DISEASE; HUMAN; HYPERTENSION; LIFESTYLE; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SCREENING; SITTING; STROKE; TACHYCARDIA; WELLBEING; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; HEALTH PROMOTION; MIDDLE AGED; MULTICENTER STUDY; OCCUPATIONAL HEALTH SERVICE; RISK FACTOR; WORKPLACE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PROMOTION; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OCCUPATIONAL HEALTH SERVICES; PREVALENCE; RISK FACTORS; WORKPLACE;

EID: 21744450433     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083439     Document Type: Article

References (29)

1. American Heart Association: 2003 Heart and Stroke Statistical Update. Dallas, American Heart Association, 2003.
2. Dawber TR, Kannel WB: The Framingham study. An epidemiological approach to coronary heart disease. Circulation 1966;34:553-555.
3. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
4. Reaven GM: Syndrome X. Blood Press Suppl 1992;4:13-16.
5. Reaven GM: Banting lecture 1988:Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
6. Meigs JB: Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000;152:908-911.
7. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, Eschwege E: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policeman Study. Diabetes Care 1998;21:360-367.
8. Meigs JB, Nathan DM, Wilson PW, Cupples LA, Singer DE: Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance: The Framingham Offspring Study. Ann Intern Med 1998;128:524-533.
9. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
10. Trevisan M, Liu J, Bahsas FB, Menotti A: Syndrome X and mortality: A population-based study: Risk factor and life expectancy research group. Am J Epidemiol 1998;148:958-966.
11. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB: Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999;159:1104-1109.
12. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-722.
13. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
14. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 1998;15:539-553.
15. Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants aged 50 years and older. Diabetes 2003;52:1210-1214.
16. Ford ES, Giles WH: A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-581.
17. National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel of Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary. Bethesda, National Institutes of Health, National Heart, Lung, and Blood Institute, 2001.
18. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among U.S. adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
19. Geslain-Biquez C, Vol S, Tichet J, Caradec A, D'Hour A, Balkau B; D.E.S.I.R. Study Group: The metabolic syndrome in smokers. The D.E.S.I.R. study. Diabetes Metab 2003;29:226-234.
20. Lakka TA, Laaksonen DE, Lakka H-M, Männikkö N, Niskanen LK, Rauramaa R, Salonen JT: Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 2003;35:1279-1286.
21. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-419.
22. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Geneva, World Health Organization, 2000, WHO Tech Rep Ser 894.
23. Jenkins DJ, Axelsen M, Kendall CW, Augustin LS, Vuksan V, Smith U: Dietary fibre, lente carbohydrates and the insulin-resistant diseases. Br J Nutr 2000;83(suppl 1):S157-S163.
24. Vessby B, Unsitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nalsen C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, Storlien LH; KANWU Study: Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001;44:312-319.
25. Summers LK, Fielding BA, Bradshaw HA, Ilic V, Beysen C, Clark ML, Moore NR, Frayn KN: Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 2002;45:369-377.
26. Elton PJ, Ryman A, Hammer M, Page F: Randomized controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration. J Epidemiol Community Health 1994;48:22-25.
27. Barratt A, Reznik R, Irwig L, Cuff A, Simpson JM, Oldenburg B, Horvath J, Sullivan D: Work-site cholesterol screening and dietary intervention: The Staff Healthy Heart Project. Am J Public Health 1994;84:779-782.
28. Engberg M, Christensen B, Karlsmose B, Lous J, Lauritzen T: General health screenings to improve cardiovascular risk profiles: A randomized controlled trial in general practice with 5-year follow-up. J Fam Pract 2002;51:546-552.
29. Mitka M: Metabolic syndrome recasts old cardiac, diabetes risk factors as a 'new' entity. JAMA 2004;291:2062-2063.